Skip to main content

Diagnosis of Chagas Disease

  • Chapter
  • First Online:
Chagas Disease

Abstract

Diagnosis of Chagas disease is related to the phase of this protozoan infection. For acute phase, parasitological methods are preferred and for the chronic phase, serological ones. Parasitological methods comprise from the simplest wet smear, going through alternatives as concentration methods and tests that involve the multiplication of the parasite in media (hemoculture), triatomine insects (xenodiagnosis), or animals (inoculation of susceptible mammals), to more sophisticated molecular tests as polymerase chain reaction (PCR) and loop-mediated isothermal amplification (LAMP). All have indications, advantages, and disadvantages, as well as costs, all of which will be detailed in this chapter. Among serological tests, a vast repertoire has been also developed and standardized, from the simplest indirect hemagglutination to the sophisticated CMIA, including indirect immunofluorescence, ELISA, and rapid tests. As all are indirect tests, it is recommended to use at least two of them for a concluding laboratory result, in order to confirm or exclude the infection by Trypanosoma cruzi. Diagnosis may be used in different contexts as confirmation of the infection, exclusion of blood donors, epidemiological survey, congenital infection, or follow-up after specific treatment. In order to have a precise diagnosis, it is necessary to have commercial kits of proved performance and good laboratory practices, for which permanent training of laboratory personnel is mandatory. An external quality control will prove that these conditions have been fulfilled.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Luquetti AO, Schmuñis GA. Diagnosis of Trypanosoma cruzi infection. Chapter 29. In: Telleria J, Tibayrenc M, editors. American Trypanosomiasis. Chagas Disease. One hundred years of research. 2nd ed. Amsterdam: Elsevier; 2017.

    Google Scholar 

  2. Luquetti AO, Rassi A. Diagnóstico Laboratorial da Infecção pelo Trypanosoma cruzi. In: Brener Z, Andrade AZ, Barral-Neto M, editors. Trypanosoma cruzi e Doença de Chagas. 2nd ed. Rio de Janeiro: Guanabara Koogan; 2000. p. 344–78.

    Google Scholar 

  3. Carlier Y, Torrico F, Sosa-Estani S, Russomando G, Luquetti AO, Freilij H, Vinas PA. Congenital Chagas disease: recommendations for diagnosis, treatment and control of newborns, siblings and pregnant women. PLoS Negl Trop Dis. 2011;5:e1250.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Luquetti AO, Ferreira MS. Diagnóstico da doença de Chagas na coinfecção T. cruzi/HIV. In: Almeida EA, editor. Epidemiologia e clínica da coinfecção Trypanosoma cruzi/HIV. Campinas: Editora Universidade Estadual de Campinas; 2015.

    Google Scholar 

  5. Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop. 2010;115:14–21.

    PubMed  Google Scholar 

  6. Zingales B, Miles MA, Campbell DA, Tibayrenc M, Macedo AM, Teixeira MM, Schijman AG, Llewellyn MS, Lages-Silva E, Machado CR, Andrade SG, Sturm NR. The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications. Infect Genet Evol. 2012;12(2):240–53. https://doi.org/10.1016/j.meegid.2011.12.009. Review.

    Article  PubMed  Google Scholar 

  7. Yun O, Lima MA, Ellman T, Chambi W, Castilho S, Flevaud L, Roddy P, Parreño F, Viñas PA, Palma PP. Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolívia: 10-year experience of Mèdecins Sans Frontières. PLoS Negl Trop Dis. 2009;3(e):488. https://doi.org/10.1371/journal.pntd.0000488.

    Article  CAS  Google Scholar 

  8. Rassi A, Rezende JM, Luquetti AO, Rassi A Jr. Clinical phases and forms of chagas disease. Chapter 28. In: Telleria J, Tibayrenc M, editors. American Trypanosomiasis. Chagas Disease. One hundred years of research. 2nd ed. Amsterdam: Elsevier; 2017.

    Google Scholar 

  9. Luquetti AO, Tavares SB, Siriano L da R, de Oliveira RA, Campos DE, de Morais CA, de Oliveira EC. Congenital transmission of Trypanosoma cruzi in central Brazil. A study of 1,211 individuals born to infected mothers. Mem Inst Oswaldo Cruz. 2015;110:369–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Strout RG. A method for concentrating hemoflagellates. J. Parasit. 1962;48:100.

    Article  CAS  PubMed  Google Scholar 

  11. Freilij H, Altcheh J. Chagas congénito. In: Storino R, Milei J, editors. Enfermedad de Chagas. Buenos Aires: Edit. Doyma; 1994.

    Google Scholar 

  12. Castro AM, Luquetti AO, Rassi A, Chiari E, Galvão LMC. Detection of parasitemia profiles by blood culture after treatment of human chronic Trypanosoma cruzi infection. Parasitology Research. 2006;99:379–83.

    Article  PubMed  Google Scholar 

  13. Santos AH, Silva IG, Rassi A. Estudo comparativo entre o xenodiagnóstico natural e o artificial em chagásicos crônicos. Rev Soc Bras Med Trop. 1995;28:367–73.

    Article  PubMed  Google Scholar 

  14. Oliveira EC, Stefani MMA, Luquetti AO, Vencio EF, Moreira MAR, Souza C, Rezende JM. Trypanosoma cruzi and experimental Chagas disease: characterization of a stock isolated from a patient with associated digestive and cardiac form. Rev Soc Bras Med Trop. 1993;26:25–33.

    Article  CAS  PubMed  Google Scholar 

  15. Avila HA, Pereira JB, Thiemann O, et al. Detection of Trypanosoma cruzi in blood specimens of chronic chagasic patients by polymerase chain reaction amplification of kinetoplast minicircle DNA: comparison with serology and xenodiagnosis. J Clin Microbiol. 1993;31:2421–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Britto C, Cardoso MA, Vanni CM, et al. Polymerase chain reaction detection of Trypanosoma cruzi in human blood samples as a tool for diagnosis and treatment evaluation. Parasitology. 1995;110(Pt 3):241–7.

    Article  CAS  PubMed  Google Scholar 

  17. Moser DR, Kirchhoff LV, Donelson JE. Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction. J Clin Microbiol. 1989;27(7):1477–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Piron M, Fisa R, Casamitjana N, et al. Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Tropica. 2007;103:195–200.

    Article  CAS  PubMed  Google Scholar 

  19. Duffy T, Cura CI, Ramirez JC, et al. Analytical performance of a multiplex real-time PCR assay using TaqMan probes for quantification of Trypanosoma cruzi satellite DNA in blood samples. PLoS Negl Trop Dis. 2013;7(1):e2000.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Ramírez JC, Cura CI, da Cruz Moreira O, et al. Analytical validation of quantitative real-time PCR methods for quantification of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. J Mol Diagn. 2015;17(5):605–15.

    Article  PubMed  Google Scholar 

  21. Schijman AG, Bisio M, Orellana L, et al. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl Trop Dis. 2011;5(1):e93.

    Article  Google Scholar 

  22. Ramírez JC, Torres C, Curto MLA, Schijman AG. New insights into Trypanosoma cruzi evolution, genotyping and molecular diagnostics from satellite DNA sequence analysis. PLoS Negl Trop Dis. 2017;11(12):e0006139.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Guhl F, Vallejo GA. Trypanosoma (Herpetosoma) rangeli Tejera, 1920: an updated review. Mem Inst Oswaldo Cruz. 2003;98:435–42.

    Article  PubMed  Google Scholar 

  24. Saldana A, Samudio F, Miranda A, et al. Predominance of Trypanosoma rangeli infection in children from a Chagas disease endemic area in the west-shore of the Panama canal. Mem Inst Oswaldo Cruz. 2005;100:729–31.

    Article  PubMed  Google Scholar 

  25. Ramírez JC, Parrado R, Sulleiro E, de la Barra A, Rodriguez M, Villarroel S, Irazu L, Alonso-Vega C, Alves F, Curto M, Garcia L, Ortiz L, Torrico F, Gascon J, Flevaud L, Molina I, Ribeiro I, Schijman AG. First External quality assurance program for real-time PCR monitoring of treatment response in clinical trials of Chagas disease. PLoS One. 2017;12(11):e0188550. https://doi.org/10.1371/journal.pone.0188550.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Mori Y, Nagamine K, Tomita N, et al. Detection of loop-mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation. Biochem Biophys Res Commun. 2001;289:150–4.

    Article  CAS  PubMed  Google Scholar 

  27. Notomi T, Okayama H, Masubuchi H, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 28: p. 2000;E63:266.

    Google Scholar 

  28. Thekisoe OM, Rodriguez CV, Rivas F, Coronel-Servian AM, Fukumoto S, Sugimoto C, et al. Detection of Trypanosoma cruzi and T. rangeli infections from Rhodnius pallescens bugs by loop-mediated isothermal amplification (LAMP). Am J Trop Med Hyg. 2010;82:855–60. https://doi.org/10.4269/ajtmh.2010.09-0533.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Rivero R, Bisio M, Velázquez EB, Esteva MI, Scollo K, González NL, Altcheh J, Ruiz AM. Rapid detection of Trypanosoma cruzi by colorimetric loop-mediated isothermal amplification (LAMP): a potential novel tool for the detection of congenital Chagas infection. Diagn Microbiol Infect Dis. 2017;89:26. https://doi.org/10.1016/j.diagmicrobio.2017.06.012. pii: S0732-8893(17)30189-X.

    Article  CAS  PubMed  Google Scholar 

  30. Besuschio SA, Llano Murcia M, Benatar AF, Monnerat S, Cruz I, Picado A, Curto MLÁ, Kubota Y, Wehrendt DP, Pavia P, Mori Y, Puerta C, Ndung’u JM, Schijman AG. Analytical sensitivity and specificity of a loop-mediated isothermal amplification (LAMP) kit prototype for detection of Trypanosoma cruzi DNA in human blood samples. PLoS Negl Trop Dis. 2017;11:e0005779.

    Article  PubMed  PubMed Central  Google Scholar 

  31. WHO. WHO technical report series no. 905. Control of Chagas Disease. Second report of the WHO Expert Committee. Geneva: World Health Organization; 2002.

    Google Scholar 

  32. Abras A, Gállego M, Llovet T, Tebar S, Herrero M, et al. Serological diagnosis of chronic Chagas disease: is it time for a change? J Clin Microbiol. 2016;54:1566–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Luquetti AO, Ponce C, Ponce E, Esfandiari J, Schijman A, Revollo S, Añez N, Zingales B, Aldao RR, Gonzalez A, Levin M, Umezawa E, Franco da Silveira J. Chagas disease diagnosis: a multicentric evaluation of Chagas Stat-Pak, a rapid immunochromatographic assay with recombinant proteins of Trypanosoma cruzi. Journal of Diagnostic Microbiology and Infectious disease. 2003;46:265–71.

    Article  CAS  PubMed  Google Scholar 

  34. Sanchez-Camargo CL, Albajar-Vinas P, Wilkins PP, Nieto J, Leiby DA, Paris L, et al. Comparative evaluation of 11 commercialized rapid diagnostic tests for detecting Trypanosoma cruzi antibodies in serum banks in areas of endemicity and nonendemicity. J Clin Microbiol. 2014;52(7):2506–12.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Castro-Sesquen YE, Gilman RH, Galdos-Cardenas G, et al. Use of a novel Chagas urine nanoparticle test (chunap) for diagnosis of congenital Chagas disease. PLoS Negl Trop Dis. 2014;8(10):e3211.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Cura CI, Lattes R, Nagel C, et al. Early molecular diagnosis of acute Chagas disease after transplantation with organs from Trypanosoma cruzi-infected donors. Am J Transplant. 2013;13:3253–61.

    Article  CAS  PubMed  Google Scholar 

  37. Affranchino JL, Ibanez CF, Luquetti AO, Rassi A, Reyes MB, Macina RA, Aslund L, Pettersson U, ACC F. Identification of a Trypanosoma cruzi antigen that is shed during the acute phase of Chagas’ disease. Mol. Bioch. Parasitol. 1989;34:221–8.

    Article  CAS  Google Scholar 

  38. Alarcon de Noya B, Diaz-Bello Z, Colmenares C, Ruiz-Guevara R, Mauriello L, Zavala-Jaspe R, et al. Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela. J Infect Dis. 2010;201:1308 1315.

    Article  Google Scholar 

  39. Shikanai-Yasuda MA, Carvalho NB. Oral transmission of Chagas disease. Clin Infect Dis. 2012;54:845–52. https://doi.org/10.1093/cid/cir956.

    Article  PubMed  Google Scholar 

  40. Silva-Dos-Santos D, Barreto-de-Albuquerque J, Guerra B, Moreira OC, Berbert LR, Ramos MT, Mascarenhas BAS, Britto C, Morrot A, Serra Villa-Verde DM, Garzoni LR, Savino W, Cotta-de-Almeida V, Meis J. Unraveling Chagas disease transmission through the oral route: gateways to T. cruzi infection and target tissues. PLoS Negl Trop Dis. 2017;11(4):e0005507. https://doi.org/10.1371/journal.pntd.0005507.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Noya BA, Díaz-Bello Z, Colmenares C, Ruiz-Guevara R, Mauriello L, Muñoz-Calderón A, Noya O. Update on oral Chagas disease outbreaks in Venezuela: epidemiological, clinical and diagnostic approaches. Mem Inst Oswaldo Cruz. 2015;110:3786. https://doi.org/10.1590/0074-02760140285. Review.

    Article  CAS  Google Scholar 

  42. Ramírez JD, Montilla M, Cucunubá ZM, Floréz AC, Zambrano P, Guhl F. Molecular epidemiology of human oral Chagas disease outbreaks in Colombia. PLoS Negl Trop Dis. 2013;7:e2041. https://doi.org/10.1371/journal.pntd.0002041.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Blanchet D, Breniere SF, Schijman AG, et al. First report of a family outbreak of Chagas disease in French Guiana and posttreatment follow-up. Infect Genet Evol. 2014;28:245–50.

    Article  PubMed  Google Scholar 

  44. Diez M, Favaloro L, Bertolotti A, Burgos JM, Vigliano C, Lastra MP, Levin MJ, Arnedo A, Nagel C, Schijman AG, Favaloro RR. Usefulness of PCR strategies for early diagnosis of Chagas’ disease reactivation and treatment follow-up in heart transplantation. Am J Transplant. 2007;7:1633–40.

    Article  CAS  PubMed  Google Scholar 

  45. Cura CI, Ramírez JC, Rodríguez M, Lopez-Albízu C, Irazu L, Scollo K, Sosa-Estani S. Comparative study and analytical verification of PCR methods for the diagnosis of congenital Chagas Disease. J Mol Diagn. 2017;19:673. pii: S1525-1578(17)30108-3.

    Article  CAS  PubMed  Google Scholar 

  46. Bua J, Volta BJ, Perrone AE, et al. How to improve the early diagnosis of Trypanosoma cruzi infection: relationship between validated conventional diagnosis and quantitative DNA amplification in congenitally infected children. PLoS Negl Trop Dis. 2013;7(10):e2476.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Schijman AG, Altcheh J, Burgos JM, et al. Aetiological treatment of congenital Chagas’ disease diagnosed and monitored by the polymerase chain reaction. J Antimicrob Chemother. 2003;52(3):441–9.

    Article  CAS  PubMed  Google Scholar 

  48. Mora MC, Sanchez-Negrette O, Marco D, et al. Early diagnosis of congenital Trypanosoma cruzi infection using PCR, hemoculture, and capillary concentration, as compared with delayed serology. J Parasitol. 2005;91:1468–73.

    Article  PubMed  Google Scholar 

  49. Messenger LA, Gilman RH, Verastegui M, Galdos-Cardenas G, Sanchez G, Valencia E, Sanchez L, Malaga E, Rendell VR, Jois M, Shah V, Santos N, Del Carmen Abastoflor M, LaFuente C, Colanzi R, Bozo R, Bern C, Working Group on Chagas disease in Bolivia and Peru. Towards improving early diagnosis of congenital Chagas disease in an endemic setting. Clin Infect Dis. 2017;65:268. https://doi.org/10.1093/cid/cix277.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Benatar AF, Besuschio SA, Bortolotti S, Ramirez JC, Cafferata ML, Danesi E, Lopez Albizu C, Ciganda A, Lara L, Agolti G, Seu S, Uequìn V, Curet L, Adamo EL, Black F, Lucero H, Esteva M, Bua J, Longhi C, MdeA S, Poeylaut-Palena A, Scollo K, Althabe F, Capriotti G, Rojkin F, Sosa Estani S, Schijman AG. Validation of a real time PCR kit prototype for early diagnosis of congenital Chagas disease in a multicenter field study. Medicina. 2017;77(Suppl I):400.

    Google Scholar 

  51. Basombrío MA, Nasser J, Segura MA, Marco D, Sánchez Negrette O, Padilla M, Mora MC. The transmission of Chagas disease in Salta and the detection of congenital cases. Medicina (B Aires). 1999;59(Suppl 2):143–6. Spanish.

    Google Scholar 

  52. Bern C. Chagas disease in the immunosuppressed host. Curr Opin Infect Dis. 2012;25:450–7.

    Article  CAS  PubMed  Google Scholar 

  53. Burgos JM, Diez M, Vigliano C, et al. Molecular identification of Trypanosoma cruzi discrete typing units in end-stage chronic Chagas heart disease and reactivation after heart transplantation. Clin Infect Dis. 2010;51:485–95.

    Article  CAS  PubMed  Google Scholar 

  54. da Costa PA, Segatto M, Durso DF, de Carvalho Moreira WJ, Junqueira LL, de Castilho FM, de Andrade SA, Gelape CL, Chiari E, Teixeira-Carvalho A, Junho Pena SD, Machado CR, Franco GR, Filho GB, Vieira Moreira MDC, Mara Macedo A. Early polymerase chain reaction detection of Chagas disease reactivation in heart transplant patients. J Heart Lung Transplant. 2017;36:797–805.

    Article  PubMed  Google Scholar 

  55. Burgos JM, Begher SB, Freitas JM, Bisio M, Duffy T, Altcheh J, Teijeiro R, Lopez Alcoba H, Deccarlini F, Freilij H, Levin MJ, Levalle J, Macedo AM, Schijman AG. Molecular diagnosis and typing of Trypanosoma cruzi populations and lineages in cerebral Chagas disease in a patient with AIDS. Am J Trop Med Hyg. 2005;73:1016–8.

    Article  PubMed  Google Scholar 

  56. Perez-Molina JA, Rodriguez-Guardado A, Soriano A, et al. Guidelines on the treatment of chronic coinfection by Trypanosoma cruzi and HIV outside endemic areas. HIV Clin Trials. 2011;12:287–98.

    Article  CAS  PubMed  Google Scholar 

  57. Almeida EA, Ramos-Junior AN, Correia D, et al. Co-infection Trypanosoma cruzi/HIV: systematic review (1980-2010). Rev Soc Bras Med Trop. 2011;44:762–70.

    Article  PubMed  Google Scholar 

  58. Torrico F, Gascon J, Lourdes O, Cristina A-V, María-Jesús P, Alejandro S, Almeida Igor C, Fabiana A, Nathalie S-W, Isabela R, on behalf of the E1224 Study Group. Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial. The Lancet Infectious Diseases. 2018;18:419.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Luquetti AO, Passos ADC, Silveira AC, Ferreira AW, Macedo V, Prata AR. O inquérito nacional de soroprevalência de avaliação do controle da doença de Chagas no Brasil (2001-2008). Rev. Soc Brasileira Medicina Tropical. 2011;44(Suppl 2):108–21.

    Article  Google Scholar 

  60. Rassi A, Luquetti AO. Capítulo 53: Critérios de Cura da Infecção pelo Trypanosoma cruzi na Espécie Humana. In: Coura JR, editor. Dinâmica das doenças infecciosas e parasitárias, vol. 1. 2nd ed. Rio de Janeiro: Guanabra Koogan; 2013. p. 729–35.

    Google Scholar 

  61. Pinazo MJ, Thomas MC, Bua J, et al. Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review. Expert Rev Anti Infect Ther. 2014;12:479–96.

    Article  CAS  PubMed  Google Scholar 

  62. Murcia L, Carrilero B, Muñoz MJ, et al. Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas’ disease: a prospective study in a non-disease-endemic country. J Antimicrob Chemother. 2010;65:1759–64.

    Article  CAS  PubMed  Google Scholar 

  63. Viotti R, Alarcon de Noya B, Araujo-Jorge T, et al. Towards a paradigm shift in the treatment of chronic Chagas disease. Antimicrob Agents Chemother. 2014;58(2):635–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Moreira OC, Ramírez JD, Velázquez E, Melo MF, Lima-Ferreira C, Guhl F, Sosa-Estani S, Marin-Neto JA, Morillo CA, Britto C. Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial. Acta Trop. 2013;125:23–31.

    Article  CAS  PubMed  Google Scholar 

  65. Alonso-Padilla J, Gallego M, Schijman AG, Gascon J. Molecular diagnostics for Chagas disease: up to date and novel methodologies. Expert Rev Mol Diagn. 2017;17:699–710.

    Article  CAS  PubMed  Google Scholar 

  66. Molina I, Gomez i Prat J, Salvador F, et al. Randomized trial of posaconazole and benznidazole for chronic Chagas’ disease. N Engl J Med. 2014;370(20):1899–908.

    Article  PubMed  Google Scholar 

  67. Morillo CA, Marin-Neto JA, Avezum A, et al. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N Engl J Med. 2015;373:1295–306.

    Article  CAS  PubMed  Google Scholar 

  68. Álvarez MG, Vigliano C, Lococo B, Bertocchi G, Viotti R. Prevention of congenital Chagas disease by benznidazole pre-treatment in reproductive-age women. An observational study. Acta Trop. 2017;174:149. https://doi.org/10.1016/j.actatropica.2017.07.004. pii: S0001-706X(16)30750-1.

    Article  CAS  PubMed  Google Scholar 

  69. Morillo CA, Waskin H, Sosa-Estani S, Del Carmen Bangher M, Cuneo C, Milesi R, Mallagray M, Apt W, Beloscar J, Gascon J, Molina I, Echeverria LE, Colombo H, Perez-Molina JA, Wyss F, Meeks B, Bonilla LR, Gao P, Wei B, McCarthy M, Yusuf S, STOP-CHAGAS Investigators. Benznidazole and posaconazole in eliminating parasites in asymptomatic T. cruzi carriers: the STOP-CHAGAS trial. J Am Coll Cardiol. 2017;69:939–47. https://doi.org/10.1016/j.jacc.2016.12.023.

    Article  CAS  PubMed  Google Scholar 

  70. Valdez F, Padilla A, Tarleton R. Identification of a rare dormant sub-population of Trypanosoma cruzi amastigotes able to reassume proliferation, infection and generation of new quiescent forms. Medicina. 2017;77(Suppl I):26.1.

    Google Scholar 

  71. WHO. Research priorities for Chagas disease, human African trypanosomiasis and Leishmaniasis. World Health Organization technical report series. Geneva: World Health Organization/Special Programme for Research and Training in Tropical Diseases (TDR); 2012. (975):v-xii, 1-100.

    Google Scholar 

  72. Schijman AG, Burgos JM, Marcet P. Molecular tools and strategies for diagnosis of Chagas Disease and leishmaniasis, Chapter 9. In: da Silva S, Cano MI, editors. Molecular and cellular biology of pathogenic trypanosomatids; Frontiers in parasitology, vol. 1. Sharjah: Bentham Science Publishers; 2016. p. 394–452.

    Google Scholar 

  73. Porras AI, Yadon ZE, Altcheh J, et al. Target product profile (TPP) for Chagas disease point-of-care diagnosis and assessment of response to treatment. PLoS Negl Trop Dis. 2015;9:e0003697.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alejandro G. Schijman .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Luquetti, A.O., Schijman, A.G. (2019). Diagnosis of Chagas Disease. In: Altcheh, J., Freilij, H. (eds) Chagas Disease. Birkhäuser Advances in Infectious Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-00054-7_7

Download citation

Publish with us

Policies and ethics